Dialysis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dialysis stocks.

Dialysis Stocks Recent News

Date Stock Title
Nov 17 DVA Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
Nov 15 FMS Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says
Nov 15 OM Outset Medical to Present at the 2024 Stifel Healthcare Conference
Nov 15 ICUI ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets
Nov 14 DVA DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation
Nov 14 AKBA Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
Nov 14 OPK NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
Nov 14 ICUI ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 13 ICUI ICU Medical, Otsuka team up to boost US IV solutions production
Nov 13 ICUI ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Nov 13 ICUI ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript
Nov 12 ICUI ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates
Nov 12 ICUI ICU Medical Non-GAAP EPS of $1.59 beats by $0.34, revenue of $589.1M beats by $12.42M
Nov 12 ICUI ICU Medical: Q3 Earnings Snapshot
Nov 12 ICUI ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
Nov 12 ICUI ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
Nov 12 DVA DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health
Nov 12 AKBA Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Nov 12 ICUI Earnings Scheduled For November 12, 2024
Dialysis

In medicine, dialysis (from Greek διάλυσις, diàlysis, "dissolution"; from διά, dià, "through", and λύσις, lỳsis, "loosening or splitting") is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy.
Dialysis is used in patients with rapidly developing loss of kidney function, called acute kidney injury (previously called acute renal failure), or slowly worsening kidney function, called Stage 5 chronic kidney disease, (previously called chronic kidney failure and end-stage renal disease and end-stage kidney disease).
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible.In the United Kingdom and the United States, dialysis is paid for by the government for those who are eligible. The first successful dialysis was performed in 1943.
In research laboratories, dialysis technique can also be used to separate molecules based on their size. Additionally, it can be used to balance buffer between a sample and the solution "dialysis bath" or "dialysate" that the sample is in. For dialysis in a laboratory, a tubular semipermeable membrane made of cellulose acetate or nitrocellulose is used. Pore size is varied according to the size separation required with larger pore sizes allowing larger molecules to pass through the membrane. Solvents, ions and buffer can diffuse easily across the semipermeable membrane, but larger molecules are unable to pass through the pores. This can be used to purify proteins of interest from a complex mixture by removing smaller proteins and molecules.

Browse All Tags